Sigyn Therapeutics Inc
(SIGY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,621 | -758 | -4,146 | -2,970 | -2,064 |
| Depreciation Amortization | 163 | 45 | 1,765 | 1,317 | 1,094 |
| Accounts payable and accrued liabilities | 27 | 68 | 197 | 34 | 12 |
| Other Working Capital | 739 | 357 | 850 | 365 | 125 |
| Other Operating Activity | 274 | 53 | -49 | -2 | -59 |
| Operating Cash Flow | $-418 | $-236 | $-1,383 | $-1,255 | $-891 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 470 | 252 | 1,312 | 1,272 | 882 |
| Other Financing Activity | -10 | 5 | 75 | 40 | 25 |
| Financing Cash Flow | $460 | $257 | $1,387 | $1,312 | $907 |
| Beginning Cash Position | 12 | 12 | 8 | 8 | 8 |
| End Cash Position | 54 | 33 | 12 | 65 | 24 |
| Net Cash Flow | $42 | $21 | $3 | $56 | $15 |
| Free Cash Flow | |||||
| Operating Cash Flow | -418 | -236 | -1,383 | -1,255 | -891 |
| Free Cash Flow | -418 | -236 | -1,383 | -1,255 | -891 |